drugset / Trial / NCT01341353
Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China
Phase 4
Unknown
1800 enrolled
Wuhan University
Capital Medical University · collabDalian Medical University · collabGuangdong Provincial People's Hospital · collabNanjing Medical University · collabPeking Union Medical College · collabShanghai Chest Hospital · collabWest China Hospital · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The mainstay of treatment for atrial fibrillation remains pharmacological;however,catheter ablation has increasingly been used over the last decades. The relative merits of each strategy have not been extensively studied. Our study was designed to determine if catheter ablation is a feasible option as first-line therapy for treating patients with symptomatic AF.
Timeline
- Start
- 2011-04
- Primary completion
- 2014-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amiodarone | Small molecule | — | — |
| Comparator | Digoxin | Other / unclassified | — | — |